These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

840 related articles for article (PubMed ID: 16644019)

  • 1. Transplantation of autologous sympathetic neurons as a potential strategy to restore metabolic functions of the damaged nigrostriatal dopamine nerve terminals in Parkinson's disease.
    Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
    Brain Res Rev; 2006 Sep; 52(2):244-56. PubMed ID: 16644019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease.
    Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
    Exp Neurol; 2004 Jul; 188(1):65-73. PubMed ID: 15191803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration.
    Carlsson T; Carta M; Muñoz A; Mattsson B; Winkler C; Kirik D; Björklund A
    Brain; 2009 Feb; 132(Pt 2):319-35. PubMed ID: 19039008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Synthesis of monoamines by non-monoaminergic neurons: illusion or reality?].
    Ugrumov MV
    J Soc Biol; 2009; 203(1):75-85. PubMed ID: 19358813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vesicular monoamine transporter-2 and aromatic L-amino acid decarboxylase gene therapy prevents development of motor complications in parkinsonian rats after chronic intermittent L-3,4-dihydroxyphenylalanine administration.
    Lee WY; Lee EA; Jeon MY; Kang HY; Park YG
    Exp Neurol; 2006 Jan; 197(1):215-24. PubMed ID: 16269145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia.
    Lindgren HS; Andersson DR; Lagerkvist S; Nissbrandt H; Cenci MA
    J Neurochem; 2010 Mar; 112(6):1465-76. PubMed ID: 20050978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sprouting of dopamine terminals and altered dopamine release and uptake in Parkinsonian dyskinaesia.
    Lee J; Zhu WM; Stanic D; Finkelstein DI; Horne MH; Henderson J; Lawrence AJ; O'Connor L; Tomas D; Drago J; Horne MK
    Brain; 2008 Jun; 131(Pt 6):1574-87. PubMed ID: 18487277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum.
    Biggs CS; Starr MS
    Synapse; 1999 Oct; 34(1):36-46. PubMed ID: 10459170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical detection of L-DOPA-derived dopamine within serotonergic fibers in the striatum and the substantia nigra pars reticulata in Parkinsonian model rats.
    Yamada H; Aimi Y; Nagatsu I; Taki K; Kudo M; Arai R
    Neurosci Res; 2007 Sep; 59(1):1-7. PubMed ID: 17586078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antiparkinsonian drug budipine stimulates the activity of aromatic L-amino acid decarboxylase and enhances L-DOPA-induced dopamine release in rat substantia nigra.
    Biggs CS; Fisher A; Starr MS
    Synapse; 1998 Nov; 30(3):309-17. PubMed ID: 9776134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peculiarities of L: -DOPA treatment of Parkinson's disease.
    Kostrzewa RM; Nowak P; Kostrzewa JP; Kostrzewa RA; Brus R
    Amino Acids; 2005 Mar; 28(2):157-64. PubMed ID: 15750845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease.
    Collier TJ; Sortwell CE; Elsworth JD; Taylor JR; Roth RH; Sladek JR; Redmond DE
    J Comp Neurol; 2002 Jan; 442(4):320-30. PubMed ID: 11793337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern of long-term sensorimotor recovery following intrastriatal and--accumbens DA micrografts in a rat model of Parkinson's disease.
    Falkenstein G; Rosenthal C; Reum T; Morgenstern R; Döbrössy M; Nikkhah G
    J Comp Neurol; 2009 Jul; 515(1):41-55. PubMed ID: 19399892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reuptake of L-DOPA-derived extracellular DA in the striatum of a rodent model of Parkinson's disease via norepinephrine transporter.
    Arai A; Tomiyama M; Kannari K; Kimura T; Suzuki C; Watanabe M; Kawarabayashi T; Shen H; Shoji M
    Synapse; 2008 Aug; 62(8):632-5. PubMed ID: 18509855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-DOPA: from a biologically inactive amino acid to a successful therapeutic agent.
    Hornykiewicz O
    Amino Acids; 2002; 23(1-3):65-70. PubMed ID: 12373520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells.
    Isacson O; Bjorklund LM; Schumacher JM
    Ann Neurol; 2003; 53 Suppl 3():S135-46; discussion S146-8. PubMed ID: 12666105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic intermittent L-DOPA treatment induces changes in dopamine release.
    Lundblad M; af Bjerkén S; Cenci MA; Pomerleau F; Gerhardt GA; Strömberg I
    J Neurochem; 2009 Feb; 108(4):998-1008. PubMed ID: 19196428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine hydroxylase cells appearing in the mouse striatum after dopamine denervation are likely to be projection neurones regulated by L-DOPA.
    Darmopil S; Muñetón-Gómez VC; de Ceballos ML; Bernson M; Moratalla R
    Eur J Neurosci; 2008 Feb; 27(3):580-92. PubMed ID: 18279311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multitracer assessment of dopamine function after transplantation of embryonic stem cell-derived neural stem cells in a primate model of Parkinson's disease.
    Muramatsu S; Okuno T; Suzuki Y; Nakayama T; Kakiuchi T; Takino N; Iida A; Ono F; Terao K; Inoue N; Nakano I; Kondo Y; Tsukada H
    Synapse; 2009 Jul; 63(7):541-8. PubMed ID: 19253400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine synthesis by non-dopaminergic neurons expressing individual complementary enzymes of the dopamine synthetic pathway in the arcuate nucleus of fetal rats.
    Ugrumov MV; Melnikova VI; Lavrentyeva AV; Kudrin VS; Rayevsky KS
    Neuroscience; 2004; 124(3):629-35. PubMed ID: 14980733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.